Healthcare Services

Atrial Fibrillation Market Expansion Outlook Through 2030 With Revenue Growth Insights

May 27, 2026June 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Will Be The Estimated Market Size Of The Atrial Fibrillation Market By 2030?

The atrial fibrillation market size has experienced rapid expansion in recent years. It is projected to grow from $15.1 billion in 2025 to $17.1 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.2%. The increase observed in the historic period is attributable to the rising prevalence of atrial fibrillation in aging populations, enhanced access to cardiac diagnostic technologies, the broader availability of anticoagulant therapies, the expansion of electrophysiology labs, and increasing awareness of stroke prevention.

The atrial fibrillation market is projected to experience substantial expansion over the coming years. By 2030, this market is anticipated to reach $27.88 billion, demonstrating a compound annual growth rate (CAGR) of 13.0%. This projected growth is driven by several factors, including a heightened demand for customized arrhythmia treatments, the increasing uptake of wearable cardiac monitoring technology, the broadening scope of hybrid treatment methods, escalating investments in electrophysiology infrastructure, and a sharpened focus on long-term rhythm management results. Key trends anticipated during this period encompass the growing prevalence of catheter ablation procedures, the expanding utilization of sophisticated cardiac mapping systems, a stronger inclination towards minimally invasive interventions, the proliferation of pharmacological rhythm control treatments, and an intensified emphasis on early detection and continuous monitoring.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

What Major Growth Factors Are Impacting The Atrial Fibrillation Market?

The growing prevalence of cardiovascular diseases is projected to propel the atrial fibrillation market. These diseases represent a category of ailments impacting the heart and blood vessels, encompassing conditions such as coronary artery disease, heart failure, and arrhythmias, which present a substantial threat to overall cardiovascular well-being. This rise in cardiovascular conditions highlights an increasing need for advanced diagnostic and therapeutic approaches, thus advancing the atrial fibrillation market as healthcare providers and relevant sectors address the escalating issues linked to the rising occurrence of these illnesses. Illustratively, in October 2024, the CDC (Centers for Disease Control and Prevention), a U.S-based government agency, stated that in 2023, cardiovascular disease was responsible for 919,032 deaths. This figure accounts for 1 in every 3 deaths. Additionally, approximately 805,000 individuals in the United States experience a heart attack annually. Consequently, the substantial global burden of cardiovascular diseases is set to stimulate the atrial fibrillation market.

Which Segment Divisions Form The Structure Of The Atrial Fibrillation Market?

The atrial fibrillation market covered in this report is segmented –

1) By Type: Surgical, Non-Surgical

2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies

3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion

4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

Subsegments:

1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures

2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures

What Trends Are Driving Changes In The Atrial Fibrillation Market?

Leading companies in the atrial fibrillation market are introducing innovative products and solutions, such as patient-centric clinical decision support tools, to strengthen their market standing. Clinical decision support tools (CDST) are software or electronic systems designed to assist healthcare professionals in making informed and timely decisions concerning patient care. These tools are developed to integrate relevant clinical information from various sources. For instance, in August 2023, GE HealthCare, a US-based multinational medical technology company, launched CardioVisio. This patient-centered clinical decision support tool aims to help doctors implement evidence-based clinical guidance, adhering to current atrial fibrillation guidelines, and to visualize longitudinal data from multiple sources pertinent to illness progression. CardioVisio for atrial fibrillation can aid cardiologists by streamlining clinician image interpretation and offering a view of the patient’s cardiac history and their entire healthcare journey, including previous diagnoses, prescribed medications, interventions, and comorbidities.

Who Are The Prominent Players Across The Atrial Fibrillation Market?

Major companies operating in the atrial fibrillation market are AtriCure Inc, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Johnson & Johnson, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Sanofi SA, Bayer AG, Pfizer Inc, Daiichi Sankyo Company Limited, AstraZeneca PLC, Biotronik SE & Co KG, Kardium Inc, Acutus Medical Inc, Apama Medical Inc, CardioFocus Inc, AliveCor Inc, iRhythm Technologies Inc, BioSig Technologies Inc

Access The Complete Atrial Fibrillation Market Report:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

Which Geographic Region Represents The Largest Atrial Fibrillation Market Share?

North America was the largest region in the atrial fibrillation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Atrial Fibrillation Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=8007&type=smp

Browse Through More Reports Similar to the Global Atrial Fibrillation Market 2026, By The Business Research Company

Wearable Heart Monitoring Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-heart-monitoring-devices-global-market-report

Cardiac Arrhythmia Monitoring Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report

Arrhythmia Monitoring Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/arrhythmia-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795